USANA Health Sciences USNA EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from USANA Health Sciences’s reported figures.
Based on trailing twelve months.
The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about USANA Health Sciences's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is USANA Health Sciences's EBITDA margin?
- USANA Health Sciences (USNA) reported EBITDA margin of 7.4% in Q1 2026.
- How has USANA Health Sciences's EBITDA margin changed year-over-year?
- USANA Health Sciences's EBITDA margin decreased by 16.3% year-over-year, from 8.8% to 7.4%.
- What is the long-term trend for USANA Health Sciences's EBITDA margin?
- Over 3 years (2022 to 2025), USANA Health Sciences's EBITDA margin has grown at a -14.5% compound annual growth rate (CAGR), from 12.1% to 7.6%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.